Oliver Rausch PhD

Oliver Rausch is Vice President Research and Development at Storm Therapeutics. He has overall responsibility for Storm’s biology platform and drug discovery pipeline, and worked closely with Storm’s scientific founders to secure the initial £12M series A investment that launched Storm in 2016.

Prior to Storm, Oliver was Programme Director at the National Institute for Health Research (NIHR) where he led industry-focussed collaboration initiatives in experimental medicine and early phase clinical trials. He has twenty years of drug discovery experience in Inflammation, Neurology and Oncology gained at Cellzome, UCB and GSK. He holds a degree in Biochemistry from the Free University Berlin and a PhD in Biochemistry and Cell Biology from the Institute of Cancer Research in London.